The move coincides with President Donald Trump’s push to increase domestic manufacturing and reduce reliance on foreign supply chains.
Pharmaceutical company Eli Lilly has announced plans to invest at least $27 billion in building four new manufacturing sites in the United States.
The investment marks a significant expansion amid rising demand for weight loss and diabetes medications. The move also coincides with President Donald Trump’s push to increase domestic manufacturing and reduce reliance on foreign supply chains. Trump has pressured pharmaceutical companies to invest in US production, warning of potential tariffs for those that manufacture abroad.
The company revealed its plans at an event in Washington, DC, attended by Trump administration officials, including Kevin Hassett, director of the White House National Economic Council, and Commerce Secretary Howard Lutnick. According to CNBC, Lutnick credited the Trump administration for the decision, saying the investment is “exactly what the Trump administration is all about, which is building and manufacturing and reshoring in America, investing in America, building in America.” He thanked Eli Lilly for “doing exactly what the president was hoping would happen.”
With this latest commitment, Eli Lilly’s total US manufacturing investments have exceeded $50 billion in recent years. Since 2020, the company has already spent $23 billion on new facilities to address supply shortages of high-demand drugs.
“This represents the largest pharmaceutical expansion investment in US history,” said CEO David Ricks. “We’re making these investments ... to prepare for the demand we anticipate for future pipeline medicines across our therapeutic areas.”
While Eli Lilly is working to develop drugs for conditions such as cancer and Alzheimer’s, its obesity and diabetes medications have drawn significant attention in recent years. The success of Zepbound and Mounjaro comes amid a growing market for GLP-1 drugs, including Novo Nordisk’s popular drugs Wegovy and Ozempic.
Powered by The Post Millennial CMS™ Comments
Join and support independent free thinkers!
We’re independent and can’t be cancelled. The establishment media is increasingly dedicated to divisive cancel culture, corporate wokeism, and political correctness, all while covering up corruption from the corridors of power. The need for fact-based journalism and thoughtful analysis has never been greater. When you support The Post Millennial, you support freedom of the press at a time when it's under direct attack. Join the ranks of independent, free thinkers by supporting us today for as little as $1.
Remind me next month
To find out what personal data we collect and how we use it, please visit our Privacy Policy
Comments